Penyembuhan dan Pencegahan pada Kecanduan Narkoba dan Zat Adiktif: Sebuah Tinjauan Pustaka

Keith Shawn Jeff Linus, High Boy Karmulrubog Hutasoi

Sari


ABSTRACT

 

Drugs and substances addiction is a chronic mental disorder that often relapses and is characterized by a strong desire to use the drug despite experiencing severe negative consequences. Further research should highlight the nature of drug addiction as a mental health problem that requires treatment and ongoing support, emphasizing the importance of understanding the complexity of addiction and its impact on individuals and society. This literature review focuses on the treatment of drugs addiction and preventing relapse. Method with Literature review. Drugs and substances addiction is a serious problem that requires appropriate handling and attention. Effective recovery efforts include cognitive behavioral therapy, drugs therapy, and combination therapy. Meanwhile, recommended prevention efforts include education on the dangers of drugs, drugs use prevention in the environment, and social support for individuals at risk of drugs addiction. Risk factors that can affect drugs addiction include individual, environmental, and social factors. It is important to pay attention to these risk factors and take appropriate preventive measures to reduce the likelihood of drugs addiction.

 

Keywords: Addiction, Drugs, Healing, Prevention

 

ABSTRAK

 

Kecanduan narkoba dan zat adiktif adalah gangguan mental kronis yang sering kambuh yang ditandai dengan keinginan yang sangat kuat untuk menggunakan obat tersebut meskipun mengalami konsekuensi negatif yang parah. Penelitian lebih lanjut harus menyoroti sifat kecanduan narkoba sebagai masalah kesehatan mental yang memerlukan pengobatan dan dukungan berkelanjutan, menekankan pentingnya memahami kompleksitas kecanduan dan dampaknya pada individu dan masyarakat. Tinjauan pustaka ini berfokus pada penyembuhan terhadap kecanduan narkoba dan mencegah kekambuhan timbul.

Metode Penelitian dengan tinjauan pustaka. Kecanduan narkoba merupakan masalah serius yang memerlukan penanganan dan perhatian yang tepat. Beberapa upaya penyembuhan yang efektif meliputi terapi perilaku kognitif, terapi obat, dan terapi gabungan. Sementara itu, upaya pencegahan yang dianjurkan meliputi edukasi tentang bahaya narkoba, pencegahan penggunaan narkoba di lingkungan, dan dukungan sosial bagi individu yang berisiko mengalami kecanduan narkoba. Faktor risiko yang dapat mempengaruhi kecanduan narkoba meliputi faktor individu, lingkungan, dan sosial. Penting untuk memperhatikan faktor risiko ini dan mengambil tindakan pencegahan yang tepat untuk mengurangi kemungkinan kecanduan narkoba.

 

Kata kunci: Kecanduan, Narkoba, Penyembuhan, Pencegahan

 


Teks Lengkap:

Download Artikel

Referensi


Al-Eitan, L. N., Rababa’h, D. M., & Alghamdi, M. A. (2021). Genetic susceptibility of opioid receptor genes polymorphism to drug addiction: A candidate-gene association study. BMC Psychiatry, 21, 1–14.

Amass, L., Ling, W., Freese, T. E., Reiber, C., Annon, J. J., Cohen, A. J., McCarty, D., Reid, M. S., Brown Jr, L. S., & Clark, C. (2004). Bringing buprenorphine-naloxone detoxification to community treatment providers: The NIDA Clinical Trials Network field experience. American Journal on Addictions, 13(sup1), S42–S66.

Balamurugan, J. (2018). Drug Abuse: Factors, Types and Prevention Measures. Journal Of.

Brock, J., & Middleton, L. S. (2021). Trading Addiction: An Analysis of Prescription and Non-Prescription Opioid Abuse.

Caputo, A. (2019). The experience of therapeutic community: Emotional and motivational dynamics of people with drug addiction following rehabilitation. International Journal of Mental Health and Addiction, 17(1), 151–165.

Coffa, D., & Snyder, H. (2019). Opioid use disorder: Medical treatment options. American Family Physician, 100(7), 416–425.

Fadaei, M. H., Farokhzadian, J., Miri, S., & Goojani, R. (2020). Promoting drug abuse preventive behaviors in adolescent students based on the health belief model. International Journal of Adolescent Medicine and Health, 34(3), 20190170.

Fluyau, D., & Charlton, T. E. (2019). Drug Addiction.

Freda, P. J., Moore, J. H., & Kranzler, H. R. (2021). The phenomics and genetics of addictive and affective comorbidity in opioid use disorder. Drug and Alcohol Dependence, 221, 108602.

Guillery, S. P. E., Hellweg, R., Kronenberg, G., Bohr, U., Kunte, H., & Enge, S. (2021). Quality of life in opioid replacement therapy: A naturalistic cross-sectional comparison of methadone/levomethadone, buprenorphine, and diamorphine patients. European Addiction Research, 27(5), 371–380.

Horseman, C., & Meyer, A. (2019). Neurobiology of addiction. Clinical Obstetrics and Gynecology, 62(1), 118–127.

Inanlou, M., Bahmani, B., Farhoudian, A., & Rafiee, F. (2020). Addiction recovery: A systematized review. Iranian Journal of Psychiatry.

Kleczkowska, P., Sulejczak, D., & Zaremba, M. (2021). Advantages and disadvantages of disulfiram coadministered with popular addictive substances. European Journal of Pharmacology, 904, 174143.

Koob, G. F., & Schulkin, J. (2019). Addiction and stress: An allostatic view. Neuroscience & Biobehavioral Reviews, 106, 245–262.

Krupitsky, E., Blokhina, E., Zvartau, E., Verbitskaya, E., Lioznov, D., Yaroslavtseva, T., Palatkin, V., Vetrova, M., Bushara, N., & Burakov, A. (2019). Slow-release naltrexone implant versus oral naltrexone for improving treatment outcomes in people with HIV who are addicted to opioids: A double-blind, placebo-controlled, randomised trial. The Lancet HIV, 6(4), e221–e229.

Lee, Y. K., Gold, M. S., & Fuehrlein, B. S. (2022). Looking beyond the opioid receptor: A desperate need for new treatments for opioid use disorder. Journal of the Neurological Sciences, 432, 120094.

Link, N. W., Ward, J. T., & Stansfield, R. (2019). Consequences of mental and physical health for reentry and recidivism: Toward a health‐based model of desistance. Criminology, 57(3), 544–573.

Liu, J., Tian, J., & Li, J. (2019). Modulating reconsolidation and extinction to regulate drug reward memory. European Journal of Neuroscience, 50(3), 2503–2512.

Ma, J., Bao, Y.-P., Wang, R.-J., Su, M.-F., Liu, M.-X., Li, J.-Q., Degenhardt, L., Farrell, M., Blow, F. C., & Ilgen, M. (2019). Effects of medication-assisted treatment on mortality among opioids users: A systematic review and meta-analysis. Molecular Psychiatry, 24(12), 1868–1883.

Manhapra, A., Chakraborty, A., & Arias, A. J. (2019). Topiramate pharmacotherapy for alcohol use disorder and other addictions: A narrative review. Journal of Addiction Medicine, 13(1), 7–22.

Nestler, E. J., & Lüscher, C. (2019). The molecular basis of drug addiction: Linking epigenetic to synaptic and circuit mechanisms. Neuron, 102(1), 48–59.

Newman, A. H., Xi, Z.-X., & Heidbreder, C. (2022). Current perspectives on selective dopamine D3 receptor antagonists/partial agonists as pharmacotherapeutics for opioid and psychostimulant use disorders.

Pantazis, C. B., & Aston‐Jones, G. (2020). Lateral septum inhibition reduces motivation for cocaine: Reversal by diazepam. Addiction Biology, 25(2), e12742.

Pham, H., Emerson, N., Sieg, J., & Seeley, S. (2020). Assessing the Rewarding Effects of Nicotine and Food in Male and Female Mice Lacking Regulator of G-protein Signaling Protein 4 and Their Wildtype Controls.

Ramadhini, A. J. B., Ramli, R. R., & Rahmatu, M. F. (2022). KARAKTERISTIK PENGGUNA NARKOBA DI POLI JIWA RSU MADANI PALU PERIODE OKTOBER-DESEMBER TAHUN 2021. Medika Alkhairaat: Jurnal Penelitian Kedokteran Dan Kesehatan, 4(1), 1–7.

Ray, L. A., Green, R., Enders, C., Leventhal, A. M., Grodin, E. N., Li, G., Lim, A., Hartwell, &L. (2021). Efficacy of combining varenicline and naltrexone for smoking cessation and drinking reduction: A randomized clinical trial. American Journal of Psychiatry, 178(9), 818–828.

Ray, L. A., Green, R., Roche, D. J., Magill, M., & Bujarski, S. (2019). Naltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta‐analysis. Addiction Biology, 24(6), 1138–1152.

Ruisoto, P., & Contador, I. (2019). The role of stress in drug addiction. An integrative review. Physiology & Behavior, 202, 62–68.

Spradlin, A., & Cuttler, C. (2019). Problems associated with using cannabis to cope with stress. Cannabis, 2(1), 29–38.

Tyson, L. D., Cheng, A., Kelleher, C., Strathie, K., Lovendoski, J., Habtemariam, Z., & Lewis, H. (2022). Acamprosate may be safer than baclofen for the treatment of alcohol use disorder in patients with cirrhosis: A first description of use in real-world clinical practice. European Journal of Gastroenterology & Hepatology, 34(5), 567–575.

Wemm, S. E., & Sinha, R. (2019). Drug-induced stress responses and addiction risk and relapse. Neurobiology of Stress, 10, 100148.

Werner, C. T., Gancarz, A. M., & Dietz, D. M. (2019). Mechanisms regulating compulsive drug behaviors. In Neural mechanisms of addiction (pp. 137–155). Elsevier.

Young, J. R., Smani, S. A., Mischel, N. A., Kritzer, M. D., Appelbaum, L. G., & Patkar, A. A. (2020). Non-invasive brain stimulation modalities for the treatment and prevention of opioid use disorder: A systematic review of the literature. Journal of Addictive Diseases, 38(2), 186–199.




DOI: https://doi.org/10.33024/mahesa.v3i2.9273

Refbacks

  • Saat ini tidak ada refbacks.


Publisher: Universitas Malahayati Lampung

Creative Commons License
Semua artikel dapat digunakan dibawah lisensi Creative Commons Attribution-ShareAlike 4.0 International License


kostenlose besucherzähler